Genetic and structural characterisation of alzheimer's disease associated variants in an Eastern Indian cohort.

IF 3.8 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Dipanwita Sadhukhan, Adreesh Mukherjee, Izaz Monir Kamal, Shreyosi Maitra, Brahmachari Somnath Vedeshachaitanya, Bidisha Bhattacharyya, Atanu Biswas, Saikat Chakrabarti, Arindam Biswas
{"title":"Genetic and structural characterisation of alzheimer's disease associated variants in an Eastern Indian cohort.","authors":"Dipanwita Sadhukhan, Adreesh Mukherjee, Izaz Monir Kamal, Shreyosi Maitra, Brahmachari Somnath Vedeshachaitanya, Bidisha Bhattacharyya, Atanu Biswas, Saikat Chakrabarti, Arindam Biswas","doi":"10.1007/s11011-026-01929-2","DOIUrl":null,"url":null,"abstract":"<p><p>Alzheimer's disease (AD) shows substantial clinical heterogeneity often caused by genetic variants contributing to both familial and early-onset forms. However, the genetic landscape of AD in the diverse Indian population remains further characterised. To identify probable pathogenic variants associated with AD, representing individuals from Eastern India and to assess their potential structural effects using molecular dynamics (MD) simulations. Whole-exome sequencing was performed in 29 radiologically confirmed AD patients. Variants identified were screened using standard in silico prediction tools and categorised according to their involvement in amyloid precursor protein (APP)-related and non-APP pathways. Molecular dynamics simulations of filtered variants in PSEN1, SORL1, and ABCA7 genes were conducted using GROMACS 2024 to assess conformational stability, flexibility (RMSD, RMSF), compactness (Rg), and solvent accessibility (SASA). Thirty-six variants across 18 genes were identified, including five pathogenic variants and 31 variants of uncertain significance. Frequently affected genes included ABCA7 (8 variants), SORL1 (3 variants), PSEN1 (two novel variants), and APP (London mutation, Val717Ile). Most patients (83.3%) had a positive family history, with a mean age at onset of 54.17 ± 11.74 years, presenting with typical AD, posterior cortical atrophy, or frontal variants. MD simulations revealed increased rigidity, altered electrostatic interactions, and disrupted ATP-binding dynamics in mutant proteins compared with wild type. This study identifies novel and known AD-associated variants in an Indian cohort and demonstrates their potential structural impact. Integrating genetic and structural analyses provides valuable insights into AD pathogenesis in underrepresented populations.</p>","PeriodicalId":18685,"journal":{"name":"Metabolic brain disease","volume":"41 1","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2026-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic brain disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11011-026-01929-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Alzheimer's disease (AD) shows substantial clinical heterogeneity often caused by genetic variants contributing to both familial and early-onset forms. However, the genetic landscape of AD in the diverse Indian population remains further characterised. To identify probable pathogenic variants associated with AD, representing individuals from Eastern India and to assess their potential structural effects using molecular dynamics (MD) simulations. Whole-exome sequencing was performed in 29 radiologically confirmed AD patients. Variants identified were screened using standard in silico prediction tools and categorised according to their involvement in amyloid precursor protein (APP)-related and non-APP pathways. Molecular dynamics simulations of filtered variants in PSEN1, SORL1, and ABCA7 genes were conducted using GROMACS 2024 to assess conformational stability, flexibility (RMSD, RMSF), compactness (Rg), and solvent accessibility (SASA). Thirty-six variants across 18 genes were identified, including five pathogenic variants and 31 variants of uncertain significance. Frequently affected genes included ABCA7 (8 variants), SORL1 (3 variants), PSEN1 (two novel variants), and APP (London mutation, Val717Ile). Most patients (83.3%) had a positive family history, with a mean age at onset of 54.17 ± 11.74 years, presenting with typical AD, posterior cortical atrophy, or frontal variants. MD simulations revealed increased rigidity, altered electrostatic interactions, and disrupted ATP-binding dynamics in mutant proteins compared with wild type. This study identifies novel and known AD-associated variants in an Indian cohort and demonstrates their potential structural impact. Integrating genetic and structural analyses provides valuable insights into AD pathogenesis in underrepresented populations.

东印度队列中阿尔茨海默病相关变异的遗传和结构特征
阿尔茨海默病(AD)表现出实质性的临床异质性,通常由家族性和早发性遗传变异引起。然而,在不同的印度人群中,AD的遗传景观仍有进一步的特征。鉴定可能与AD相关的致病变异,代表来自印度东部的个体,并利用分子动力学(MD)模拟评估其潜在的结构影响。对29例经放射学证实的AD患者进行了全外显子组测序。使用标准的计算机预测工具筛选鉴定出的变异,并根据其参与淀粉样蛋白前体蛋白(APP)相关和非APP途径进行分类。使用GROMACS 2024对PSEN1、SORL1和ABCA7基因过滤后的变异进行分子动力学模拟,以评估构象稳定性、柔韧性(RMSD、RMSF)、致密性(Rg)和溶剂可及性(SASA)。共鉴定出18个基因中的36个变异,包括5个致病变异和31个不确定意义的变异。常受影响的基因包括ABCA7(8个变体)、SORL1(3个变体)、PSEN1(2个新变体)和APP(伦敦突变,Val717Ile)。大多数患者(83.3%)有阳性家族史,平均发病年龄为54.17±11.74岁,表现为典型的AD、后皮层萎缩或额叶变异。MD模拟显示,与野生型相比,突变蛋白的刚性增加,静电相互作用改变,atp结合动力学中断。本研究在印度人群中确定了新的和已知的ad相关变异,并证明了它们潜在的结构影响。整合遗传和结构分析为阿尔茨海默病在未被充分代表的人群中的发病机制提供了宝贵的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Metabolic brain disease
Metabolic brain disease 医学-内分泌学与代谢
CiteScore
5.90
自引率
5.60%
发文量
248
审稿时长
6-12 weeks
期刊介绍: Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书